Systemic inflammation prevalence in patients with atherosclerotic cardiovascular disease and chronic kidney disease: a population-based study using a nationwide primary care database in Spain

IntroductionSystemic inflammation is recognised as a critical driver of atherosclerotic cardiovascular disease (ASCVD), especially in patients with comorbid chronic kidney disease (CKD). This study aims to assess the prevalence of systemic inflammation in the ASCVD population in Spain.MethodsOutpati...

Full description

Bibliographic Details
Published in:	Frontiers in Cardiovascular Medicine
Main Authors:	Giancarlo Pesce, Gaelle Gusto, Pierre Johansen, Artak Khachatryan, Bernabe Lopez-Ledesma, Jelena Vukmirica, Aleix Cases
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Subjects:	atherosclerotic cardiovascular disease chronic kidney disease systemic inflammation C-reactive protein undertreatment
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1538466/full

Similar Items

Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study
by: Hyungtae Kim, et al.
Published: (2019-08-01)

A Comparative Analysis of Different Fractional Optimal Control Strategies to Eradicate Bayoud Disease in Date Palm Trees
by: Muhammad Imran, et al.
Published: (2025-04-01)

Propensity score matched analysis of nationwide outcomes for intracranial bypass and stenting for treatment of intracranial atherosclerotic disease
by: Michael G. Brandel, et al.
Published: (2025-07-01)

Age‐Related Associations of Low‐Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population‐Based Cohort Study
by: Han Na Jung, et al.
Published: (2022-05-01)

10-YEAR RISK ESTIMATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS
by: Olha M. Chernatska, et al.
Published: (2021-06-01)

Ethics of overtreatment and undertreatment in older adults with cancer
by: Clark DuMontier, et al.
Published: (2025-07-01)

Underdiagnosis and Undertreatment of Modifiable Cardiovascular Risk Factors Among Survivors of Childhood Cancer
by: Eric J. Chow, et al.
Published: (2022-06-01)

Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies
by: Iain A. Gillespie, et al.
Published: (2023-07-01)

Clinical burden and management gaps in atherosclerotic cardiovascular disease: A nationwide study of 687,212 patients in Taiwan, 2017–2023
by: Fei-Yuan Hsiao, et al.
Published: (2025-10-01)

Aspirin for Prevention of Atherosclerotic Cardiovascular Disease
by: Soneil Guptha, Eteri Tsetskhladze, Leena S Guptha, Rajeev Gupta
Published: (2025-03-01)

Association of homocysteine with traditional and non-traditional risk factors in patients with atherosclerotic vascular disease
by: Emina Kiseljaković, et al.
Published: (2011-02-01)

Atherosclerotic Cardiovascular Diseases in Middle Delta of Egypt: A Systematic Analysis of Risk Factors Associated with the Rising Burden of the Disease
by: Mohamed Khalfallah, et al.
Published: (2025-02-01)

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
by: Roberto Gabbiadini, et al.
Published: (2023-05-01)

Metabolic syndrome and atherosclerotic cardiovascular disease risk assessment among adult patients with Thyroid diseases in Chemchemal chronic disease control center-Sulaimania
by: Imdad Ahmed Mohammed, et al.
Published: (2022-06-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Guillaume Marquis‐Gravel, et al.
Published: (2024-02-01)

The relationship between atherosclerotic disease and relapse during ATD treatment
by: Xinxin Zhu, et al.
Published: (2022-10-01)

Computational Fluid Dynamics in Intracranial Atherosclerotic Disease
by: Ahmad A. Ballout, et al.
Published: (2024-01-01)

Higher tendency of undertreatment in older patients with laryngeal cancer in Brazil
by: Ana Luiza Fassizoli da Fonte, et al.
Published: (2025-06-01)

Impact of the COVID-19 Pandemic on Elective and Emergency Inpatient Procedure Volumes in Switzerland – A Retrospective Study Based on Insurance Claims Data
by: Yael Rachamin, et al.
Published: (2023-12-01)

Trajectories of atherosclerotic cardiovascular disease risk scores as a predictor for incident chronic kidney disease
by: Hye Sun Lee, et al.
Published: (2024-04-01)

Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
by: Saket Girotra, et al.
Published: (2023-10-01)

Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
by: Stamatios Lampsas, et al.
Published: (2023-01-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

Obesity and Atherosclerotic Cardiovascular Disease: A Review of Social and Biobehavioral Pathways
by: Izza Shahid, et al.
Published: (2025-02-01)

Comparative analysis of atherosclerotic cardiovascular disease burden between ages 20–54 and over 55 years: insights from the Global Burden of Disease Study 2019
by: Ziyi Li, et al.
Published: (2024-07-01)

Atherosclerotic cardiovascular disease burden in Ghana: A scoping review
by: Francis Agyekum, et al.
Published: (2023-01-01)

A novel subtype classification for acute intracranial atherosclerotic disease-related occlusion
by: Shujuan Gan, et al.
Published: (2025-10-01)

Editorial: Intracranial atherosclerotic disease: epidemiology, imaging, treatment and prognosis, volume II
by: Xinyi Leng, et al.
Published: (2023-11-01)

Prevalence and clinical characteristics of patients with hsCRP testing and test-confirmed systemic inflammation among individuals with atherosclerotic cardiovascular disease with or without chronic kidney disease in the United States (PLUTUS)
by: Lei Lv, et al.
Published: (2025-03-01)

Correlation between carotid and/or subclavian atherosclerotic plaque and coronary atherosclerotic disease
by: Jing Li, et al.
Published: (2024-11-01)

Implementation of an Oncogeriatric Unit for Frail Older Patients with Breast Cancer: Preliminary Results
by: Helena Hipólito-Reis, et al.
Published: (2024-12-01)

Pharmacotherapeutic undertreatment of ADHD in elite-level cycling and anti-doping regulations <subtitle>Preliminary analysis from 2020–2021</subtitle>
by: Michael Liebrenz, et al.
Published: (2022-11-01)

Evaluation of Atherosclerotic Cardiovascular Disease Risk Score in Medical Residents of Imam Hossein Hospital: A Cross-Sectional Study
by: Roxana Sadeghi, et al.
Published: (2025-07-01)

Associations of serum uric acid, risk of atherosclerotic cardiovascular disease, and mortality: results from NHANES
by: Rundong Chen, et al.
Published: (2025-04-01)

Ten‐Year Risk Equations for Incident Heart Failure in Established Atherosclerotic Cardiovascular Disease Populations
by: Luke P. Dawson, et al.
Published: (2024-06-01)

Analysis of influencing factors for primary membranous nephropathy complicated with atherosclerotic cardiovascular disease and establishment of a nomogram prediction model
by: Mirixiatijiang· Maimaiti, et al.
Published: (2025-03-01)

Analysis of influencing factors for primary membranous nephropathy complicated with atherosclerotic cardiovascular disease and establishment of a nomogram prediction model
by: Mirixiatijiang· Maimaiti, et al.
Published: (2025-03-01)

An inverse association of dietary choline with atherosclerotic cardiovascular disease among US adults: a cross-sectional NHANES analysis
by: Hui Lin, et al.
Published: (2024-05-01)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
by: Michael M. Hammond, et al.
Published: (2023-04-01)

Genetic Predisposition of Atherosclerotic Cardiovascular Disease in Ancient Human Remains
by: Christina Wurst, et al.
Published: (2024-01-01)